A feasibility study tested CBD's effectiveness in reducing cannabis withdrawal symptoms during a 6-night inpatient detox. The single-subject repeated measures design assessed one subject at baseline, post-intervention, and follow-up, then replicated with 7 additional participants. CBD doses ranged from 300mg to 1200mg/day. The study concluded, with findings supporting CBD's safety and acceptability, prompting preparation for a double-blind RCT and publication.